What is IPCALAB.NS's gross margin?

Ipca (IPCALAB.NS) has a gross margin of 71% and a net margin of 13%.

What is IPCALAB.NS's P/E ratio?

IPCALAB.NS's P/E ratio is 38.3 with ROE of 15%.

Where can I see IPCALAB.NS's full financials?

See Ipca (IPCALAB.NS) income statement, cash flow, and balance sheet — quarterly and annual — alongside insider trading activity.

Ipca (IPCALAB.NS) Financials — Revenue, Earnings, Cash Flow

Also trades as: IPCALAB.BO (BSE) · $vol 1M

₹1,964.70 ($20.40)

+21.50 (+1.11%)

NSE · Healthcare · Drug Manufacturers - Specialty & Generic · Tech Score Neutral · Power 49 · ₹493.5B mcap · 139M float · 0.256% daily turnover

Overview Chart Financials Income Statement Cash Flow Balance Sheet Earnings

Analysis Technicals Weather Peers ETF Exposure

📊 Key Metrics

TTM

₹96B

Revenue

+7.9% YoY

₹11B

Net Income

+54.7% YoY

₹7B

Free Cash Flow

+31.4% YoY

71.0%

Gross Margin

15.8%

Op. Margin

12.5%

Net Margin

💰 Income Flow

How revenue becomes profit

💵 Cash Flow

Where cash goes

🏦 Balance Sheet

Assets = Liabilities + Equity

📈 Financial Health

Profitability

ROE15.2%

ROA9.5%

ROIC22.9%

Valuation

P/E38.3

P/B6.2

EV/EBITDA19.9

Leverage

Debt/Equity0.10

Current Ratio2.76

Interest Cov.21.2x

Quality Scores

Piotroski F9/9

Altman Z10.17

Beneish M-2.68